Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

Rivaroxaban suppresses factor Xa-Driven PAR-2-ERK inflammatory, catabolic, osteoclastogenic, and mitochondrial dysfunction signaling in osteoarthritis-relevant chondrocytes: a drug-repurposing strategy for joint inflammation.

Patnaik R et al. · 2026
NCBI PubMed Central · Papers · License: Open Access · 2026
Open Source ↗Direct PDF ↓
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 923516
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.